The relationship between oscillatory activity and motor reaction time in the parkinsonian subthalamic nucleus.

PubWeight™: 1.15‹?› | Rank: Top 10%

🔗 View Article (PMID 15654862)

Published in Eur J Neurosci on January 01, 2005

Authors

David Williams1, Andrea Kühn, Andreas Kupsch, Marina Tijssen, Gerard van Bruggen, Hans Speelman, Gary Hotton, Constantinos Loukas, Peter Brown

Author Affiliations

1: Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, Queen Square, London WC1N 3BG, UK.

Associated clinical trials:

Motor Control During Rapid Eye Movement (REM) Sleep Behaviour Disorder (RevesParkNST) | NCT01886131

Articles citing this

Therapeutic deep brain stimulation reduces cortical phase-amplitude coupling in Parkinson's disease. Nat Neurosci (2015) 4.01

Parkinsonian beta oscillations in the external globus pallidus and their relationship with subthalamic nucleus activity. J Neurosci (2008) 2.34

Basal ganglia beta oscillations accompany cue utilization. Neuron (2012) 1.63

Subthalamic nucleus stimulation influences expression and suppression of impulsive behaviour in Parkinson's disease. Brain (2010) 1.37

Movement-related changes in local and long-range synchronization in Parkinson's disease revealed by simultaneous magnetoencephalography and intracranial recordings. J Neurosci (2012) 1.23

Beta frequency synchronization in basal ganglia output during rest and walk in a hemiparkinsonian rat. Exp Neurol (2009) 1.14

Does suppression of oscillatory synchronisation mediate some of the therapeutic effects of DBS in patients with Parkinson's disease? Front Integr Neurosci (2012) 1.08

Movement-related frequency modulation of beta oscillatory activity in the human subthalamic nucleus. J Physiol (2005) 1.08

The highs and lows of beta activity in cortico-basal ganglia loops. Eur J Neurosci (2014) 1.05

Dopamine-dependent non-linear correlation between subthalamic rhythms in Parkinson's disease. J Physiol (2006) 1.04

Effects of dopamine depletion on information flow between the subthalamic nucleus and external globus pallidus. J Neurophysiol (2011) 1.03

Beta reactivity, prospective facilitation of executive processing, and its dependence on dopaminergic therapy in Parkinson's disease. J Neurosci (2012) 1.01

Relationship between oscillatory activity in the cortico-basal ganglia network and parkinsonism in MPTP-treated monkeys. Neurobiol Dis (2014) 0.97

Basal ganglia activity patterns in parkinsonism and computational modeling of their downstream effects. Eur J Neurosci (2012) 0.97

Effects of dopamine depletion on network entropy in the external globus pallidus. J Neurophysiol (2009) 0.91

Involvement of the subthalamic nucleus in engagement with behaviourally relevant stimuli. Eur J Neurosci (2009) 0.79

Trained modulation of sensorimotor rhythms can affect reaction time. Clin Neurophysiol (2011) 0.78

Identifying the Basal Ganglia network model markers for medication-induced impulsivity in Parkinson's disease patients. PLoS One (2015) 0.78

The Striatum and Subthalamic Nucleus as Independent and Collaborative Structures in Motor Control. Front Syst Neurosci (2016) 0.77

Morphological changes of glutamatergic synapses in animal models of Parkinson's disease. Front Neuroanat (2015) 0.76

Reduced cortical innervation of the subthalamic nucleus in MPTP-treated parkinsonian monkeys. Brain (2015) 0.76

High post-movement parietal low-beta power during rhythmic tapping facilitates performance in a stop task. Eur J Neurosci (2016) 0.76

Investigating irregularly patterned deep brain stimulation signal design using biophysical models. Front Comput Neurosci (2015) 0.75

Neuronal firing patterns outweigh circuitry oscillations in parkinsonian motor control. J Clin Invest (2016) 0.75

Subthalamic nucleus beta and gamma activity is modulated depending on the level of imagined grip force. Exp Neurol (2017) 0.75

Movement-Related Activity of Human Subthalamic Neurons during a Reach-to-Grasp Task. Front Hum Neurosci (2017) 0.75

Articles by these authors

A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med (2006) 8.12

Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease. Ann Neurol (2006) 5.49

The brain of LB1, Homo floresiensis. Science (2005) 5.10

Pathological synchronization in Parkinson's disease: networks, models and treatments. Trends Neurosci (2007) 5.10

Event-related beta desynchronization in human subthalamic nucleus correlates with motor performance. Brain (2004) 3.36

Adaptive deep brain stimulation in advanced Parkinson disease. Ann Neurol (2013) 3.05

Pathological synchronisation in the subthalamic nucleus of patients with Parkinson's disease relates to both bradykinesia and rigidity. Exp Neurol (2008) 3.00

Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group. Blood (2008) 2.95

Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study. Lancet Neurol (2008) 2.83

High-frequency stimulation of the subthalamic nucleus suppresses oscillatory beta activity in patients with Parkinson's disease in parallel with improvement in motor performance. J Neurosci (2008) 2.65

In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease. Neurobiol Dis (2005) 2.59

Boosting cortical activity at Beta-band frequencies slows movement in humans. Curr Biol (2009) 2.51

Resting oscillatory cortico-subthalamic connectivity in patients with Parkinson's disease. Brain (2010) 2.47

Healthy nature healthy people: 'contact with nature' as an upstream health promotion intervention for populations. Health Promot Int (2005) 2.44

Parkinsonian beta oscillations in the external globus pallidus and their relationship with subthalamic nucleus activity. J Neurosci (2008) 2.34

Reduction in subthalamic 8-35 Hz oscillatory activity correlates with clinical improvement in Parkinson's disease. Eur J Neurosci (2006) 2.29

Inside the brain of an elite athlete: the neural processes that support high achievement in sports. Nat Rev Neurosci (2009) 2.25

New insights into the relationship between dopamine, beta oscillations and motor function. Trends Neurosci (2011) 2.20

Disrupted dopamine transmission and the emergence of exaggerated beta oscillations in subthalamic nucleus and cerebral cortex. J Neurosci (2008) 2.16

Dopamine-dependent changes in the functional connectivity between basal ganglia and cerebral cortex in humans. Brain (2002) 2.15

Movement-related changes in synchronization in the human basal ganglia. Brain (2002) 2.15

Area of submucosal invasion and width of invasion predicts lymph node metastasis in pT1 colorectal cancers. Dis Colon Rectum (2015) 2.07

Key messages from the National Prospective Tonsillectomy Audit. Laryngoscope (2007) 2.02

The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict? Otolaryngol Head Neck Surg (2007) 2.00

Existing motor state is favored at the expense of new movement during 13-35 Hz oscillatory synchrony in the human corticospinal system. J Neurosci (2005) 1.93

Pallidal deep brain stimulation in patients with primary generalised or segmental dystonia: 5-year follow-up of a randomised trial. Lancet Neurol (2012) 1.93

Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01. J Clin Oncol (2012) 1.87

Dopamine depletion increases the power and coherence of beta-oscillations in the cerebral cortex and subthalamic nucleus of the awake rat. Eur J Neurosci (2005) 1.85

Intra-operative recordings of local field potentials can help localize the subthalamic nucleus in Parkinson's disease surgery. Exp Neurol (2006) 1.84

The relationship between local field potential and neuronal discharge in the subthalamic nucleus of patients with Parkinson's disease. Exp Neurol (2005) 1.83

Excessive synchronization of basal ganglia neurons at 20 Hz slows movement in Parkinson's disease. Exp Neurol (2007) 1.80

Myoclonus: current concepts and recent advances. Lancet Neurol (2004) 1.80

The trajectory, structure and origin of the Chelyabinsk asteroidal impactor. Nature (2013) 1.72

Oscillatory activity in the pedunculopontine area of patients with Parkinson's disease. Exp Neurol (2008) 1.71

Risk of emergency admission while awaiting elective cholecystectomy. CMAJ (2003) 1.69

Natural history and syndromic associations of orthostatic tremor: a review of 41 patients. Mov Disord (2004) 1.69

Primary orthostatic tremor is an exaggeration of a physiological response to instability. Mov Disord (2003) 1.67

Enriched environment induces cellular plasticity in the adult substantia nigra and improves motor behavior function in the 6-OHDA rat model of Parkinson's disease. Exp Neurol (2005) 1.59

Corticobasal degeneration syndrome with basal ganglia calcification: Fahr's disease as a corticobasal look-alike? Mov Disord (2002) 1.57

Frequency specific activity in subthalamic nucleus correlates with hand bradykinesia in Parkinson's disease. Exp Neurol (2012) 1.55

Driving oscillatory activity in the human cortex enhances motor performance. Curr Biol (2012) 1.54

Neuronal oscillations in the basal ganglia and movement disorders: evidence from whole animal and human recordings. J Neurosci (2004) 1.50

Cortico-cortical coupling in Parkinson's disease and its modulation by therapy. Brain (2005) 1.49

The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT). Blood (2009) 1.49

Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur. Br J Haematol (2012) 1.48

Tremor suppression by rhythmic transcranial current stimulation. Curr Biol (2013) 1.47

In vivo assessment of brain monoamine systems in parkin gene carriers: a PET study. Exp Neurol (2010) 1.47

Patterns of bidirectional communication between cortex and basal ganglia during movement in patients with Parkinson disease. J Neurosci (2008) 1.47

Different functional loops between cerebral cortex and the subthalmic area in Parkinson's disease. Cereb Cortex (2005) 1.46

Long-term assessment of striatal dopamine transporters in Parkinsonian patients with intrastriatal embryonic mesencephalic grafts. Eur J Nucl Med Mol Imaging (2006) 1.46

Ablation of the subthalamic nucleus protects dopaminergic phenotype but not cell survival in a rat model of Parkinson's disease. Exp Neurol (2004) 1.45

Cognitive deficits and striato-frontal dopamine release in Parkinson's disease. Brain (2008) 1.45

Persistent suppression of subthalamic beta-band activity during rhythmic finger tapping in Parkinson's disease. Clin Neurophysiol (2012) 1.43

Prognostic impact of clinician-based interpretation of 18F-fluorodeoxyglucose positron emission tomography/computed tomography reports obtained in patients with newly diagnosed diffuse large B-cell lymphoma. Leuk Lymphoma (2013) 1.42

Patterning of globus pallidus local field potentials differs between Parkinson's disease and dystonia. Brain (2003) 1.40

Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphoma. Haematologica (2013) 1.40

Ocular flutter in a patient with intracranial hypertension following cerebral venous thrombosis. Neurology (2002) 1.39

Modulation of beta oscillations in the subthalamic area during motor imagery in Parkinson's disease. Brain (2005) 1.35

Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease. Arch Neurol (2007) 1.34

Myoclonus-dystonia syndrome: epsilon-sarcoglycan mutations and phenotype. Ann Neurol (2002) 1.33

Alterations in brain connectivity underlying beta oscillations in Parkinsonism. PLoS Comput Biol (2011) 1.32

What brain signals are suitable for feedback control of deep brain stimulation in Parkinson's disease? Ann N Y Acad Sci (2012) 1.31

Synchronous unit activity and local field potentials evoked in the subthalamic nucleus by cortical stimulation. J Neurophysiol (2004) 1.31

Effects of low-frequency stimulation of the subthalamic nucleus on movement in Parkinson's disease. Exp Neurol (2007) 1.29

Double-blind clinical trial of thalamic stimulation in patients with Tourette syndrome. Brain (2011) 1.27

Nonsense mutations in CABC1/ADCK3 cause progressive cerebellar ataxia and atrophy. Mitochondrion (2010) 1.24

The COMBREX project: design, methodology, and initial results. PLoS Biol (2013) 1.24

Movement-related changes in local and long-range synchronization in Parkinson's disease revealed by simultaneous magnetoencephalography and intracranial recordings. J Neurosci (2012) 1.23

Motor inhibition in patients with Gilles de la Tourette syndrome: functional activation patterns as revealed by EEG coherence. Brain (2004) 1.21

Genes associated with Parkinson syndrome. J Neurol (2008) 1.21

Elevations in local gamma activity are accompanied by changes in the firing rate and information coding capacity of neurons in the region of the subthalamic nucleus in Parkinson's disease. Exp Neurol (2006) 1.21

Synchronized neural oscillations and the pathophysiology of Parkinson's disease. Curr Opin Neurol (2013) 1.19

Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and [(11)C] (R)-PK11195 PET (MEMSA-trial). Mov Disord (2010) 1.18

Oscillations and the basal ganglia: motor control and beyond. Neuroimage (2013) 1.17

Risk and learning in impulsive and nonimpulsive patients with Parkinson's disease. Mov Disord (2010) 1.17

Defective cortical drive to muscle in Parkinson's disease and its improvement with levodopa. Brain (2002) 1.17

Anticipatory changes in beta synchrony in the human corticospinal system and associated improvements in task performance. Eur J Neurosci (2007) 1.17

Dopaminergic therapy promotes lateralized motor activity in the subthalamic area in Parkinson's disease. Brain (2007) 1.16

Comparing exercise in Parkinson's disease--the Berlin LSVT®BIG study. Mov Disord (2010) 1.15

Complexity of subthalamic 13-35 Hz oscillatory activity directly correlates with clinical impairment in patients with Parkinson's disease. Exp Neurol (2010) 1.15

Synchronisation in the beta frequency-band--the bad boy of parkinsonism or an innocent bystander? Exp Neurol (2009) 1.14

Deep brain stimulation of the subthalamic nucleus: a two-edged sword. Curr Biol (2006) 1.13